Terumo BCT

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Terumo BCT sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

Terumo BCT: 12 sponsored US clinical trials, none currently recruiting.

Terumo BCT sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. The most-studied condition in this pipeline is Mononuclear (MNC) Cell Donors, with 1 trials.

Top-decile sponsor footprint

Terumo BCT ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED NA

Trima Non-DEHP Leukoreduced Red Blood Cell In Vivo Recovery Study

NCT06602804
COMPLETED NA

An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System

NCT05239455
COMPLETED NA

In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

NCT03097289
COMPLETED NA

Evaluation of Trima Version 7.0 Platelets in PAS

NCT02754440
COMPLETED NA

Evaluation of Trima Version 7.0 Platelets in 100% Plasma

NCT02754492
COMPLETED NA

Trima Accel® System Post Count Algorithm Study

NCT02684630
COMPLETED NA

In Vitro Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution

NCT02298842
COMPLETED NA

An Evaluation of the Spectra Optia CMNC Collection Procedure

NCT02253160
COMPLETED NA

Evaluation of the Spectra Optia PMN Cell Collection Procedure

NCT01805180
COMPLETED NA

Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

NCT01736657
COMPLETED NA

Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure

NCT01292486
COMPLETED

Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Healthy Blood Donors

NCT01277549

Therapeutic Areas

Mononuclear (MNC) Cell Donors 1
Healthy Apheresis Donors 1
Device Validation of In-vivo Performance 1

How the Terumo BCT archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Mononuclear (MNC) Cell Donors (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Terumo BCT: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Terumo BCT sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Terumo BCTAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
Terumo BCT sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Terumo BCT sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Terumo BCT page

12 registered trials is a research-attention snapshot, not an endorsement of Terumo BCT or any single study.

  • None of Terumo BCT's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Mononuclear (MNC) Cell Donors is the condition Terumo BCT studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mononuclear (MNC) Cell Donors trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Terumo BCT pipeline card: 12 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.